Latest Earnings
Equities
Stock Analysis
Stock Movers
Deals
Gainers And Losers
IPOs
Technology
Artificial Intelligence
Web Stories
Benzinga Inspire
Ken Loricchio
Benzinga Contributor
A New Era For Kratom: What The Latest FDA Study Reveals About Kratom Leaf
|
For years, kratom has been clouded by controversy, largely fueled by media portrayals that paint a negative picture of this natural plant. Much of the confusion stems from a lack of distinction between kratom leaf and its more concentrated extracts, leading to a fragmented and inconsistent regulatory landscape.
